Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Other Non Operating Income of $38000.0 in Q1 2026, up 138.78% quarter-over-quarter from -$98000.0 in Q4 2025, and up 1800.0% on a YoY basis from $2000.0 in Q1 2025.
Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $38000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 1800.0% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $31000.0 (up 3200.0% YoY), while the FY2025 annual figure was -$5000.0, down 125.0% from the prior year.
- Other Non Operating Income was $38000.0 for Q1 2026 at Organogenesis Holdings, up from -$98000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $73000.0 in Q2 2025 to a low of -$98000.0 in Q4 2025.
- Historically, Other Non Operating Income has averaged $5705.9 across 5 years, with a median of $6000.0 in 2022.
- The sharpest annual moves came in 2023 and 2026: Other Non Operating Income tumbled 516.67% in 2023, then surged 1800.0% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at $6000.0 in 2022, then sank by 516.67% to -$25000.0 in 2023, then dropped by 8.0% to -$27000.0 in 2024, then plunged by 262.96% to -$98000.0 in 2025, then soared by 138.78% to $38000.0 in 2026.
- The last three Other Non Operating Income figures came in at $38000.0 (Q1 2026), -$98000.0 (Q4 2025), and $18000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,000.00 |
| Dec 31, 2025 | -98,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | -28,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -21,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -1.88 Mn |
| Sep 30, 2021 | -19,000.00 |
| Jun 30, 2021 | 18,000.00 |